UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by WealthTrust Axiom LLC

WealthTrust Axiom LLC grew its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 6.7% in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,675 shares of the healthcare conglomerate’s stock after acquiring an additional 105 shares during the quarter. WealthTrust Axiom LLC’s holdings in UnitedHealth Group were worth $854,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Intercontinental Wealth Advisors LLC increased its stake in shares of UnitedHealth Group by 39.2% in the 1st quarter. Intercontinental Wealth Advisors LLC now owns 1,246 shares of the healthcare conglomerate’s stock worth $635,000 after acquiring an additional 351 shares during the last quarter. Checchi Capital Advisers LLC grew its holdings in shares of UnitedHealth Group by 1.0% during the 1st quarter. Checchi Capital Advisers LLC now owns 10,953 shares of the healthcare conglomerate’s stock worth $5,586,000 after purchasing an additional 113 shares during the period. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its holdings in shares of UnitedHealth Group by 7.7% during the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 672,079 shares of the healthcare conglomerate’s stock worth $342,740,000 after purchasing an additional 47,870 shares during the period. Tredje AP fonden grew its holdings in shares of UnitedHealth Group by 2.3% during the 1st quarter. Tredje AP fonden now owns 133,328 shares of the healthcare conglomerate’s stock worth $67,993,000 after purchasing an additional 3,000 shares during the period. Finally, Banque Cantonale Vaudoise grew its holdings in shares of UnitedHealth Group by 0.9% during the 1st quarter. Banque Cantonale Vaudoise now owns 23,544 shares of the healthcare conglomerate’s stock worth $12,006,000 after purchasing an additional 199 shares during the period. 87.48% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Stock Down 0.3 %

Shares of NYSE UNH traded down $1.60 during midday trading on Friday, hitting $532.15. 61,520 shares of the company’s stock were exchanged, compared to its average volume of 2,834,317. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.77 and a quick ratio of 0.78. UnitedHealth Group Incorporated has a twelve month low of $383.12 and a twelve month high of $553.29. The company has a market cap of $499.25 billion, a PE ratio of 27.87, a P/E/G ratio of 1.67 and a beta of 0.76. The firm’s fifty day simple moving average is $505.90 and its 200-day simple moving average is $498.93.

UnitedHealth Group (NYSE:UNHGet Rating) last issued its earnings results on Friday, July 15th. The healthcare conglomerate reported $5.57 earnings per share for the quarter, topping the consensus estimate of $5.24 by $0.33. The business had revenue of $80.33 billion for the quarter, compared to analyst estimates of $79.68 billion. UnitedHealth Group had a return on equity of 25.45% and a net margin of 5.95%. The business’s quarterly revenue was up 12.6% on a year-over-year basis. During the same quarter last year, the company earned $4.70 EPS. Research analysts predict that UnitedHealth Group Incorporated will post 21.86 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, June 28th. Shareholders of record on Monday, June 20th were given a dividend of $1.65 per share. This is a positive change from UnitedHealth Group’s previous quarterly dividend of $1.45. The ex-dividend date was Thursday, June 16th. This represents a $6.60 annualized dividend and a yield of 1.24%. UnitedHealth Group’s payout ratio is 34.46%.

Insiders Place Their Bets

In other UnitedHealth Group news, CFO John F. Rex sold 13,183 shares of UnitedHealth Group stock in a transaction that occurred on Friday, July 29th. The stock was sold at an average price of $541.53, for a total transaction of $7,138,989.99. Following the transaction, the chief financial officer now owns 141,508 shares of the company’s stock, valued at $76,630,827.24. The transaction was disclosed in a filing with the SEC, which is available at this link. In other UnitedHealth Group news, Director Richard T. Burke sold 2,500 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, May 19th. The stock was sold at an average price of $478.96, for a total value of $1,197,400.00. Following the transaction, the director now directly owns 1,215,000 shares in the company, valued at approximately $581,936,400. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO John F. Rex sold 13,183 shares of UnitedHealth Group stock in a transaction that occurred on Friday, July 29th. The shares were sold at an average price of $541.53, for a total value of $7,138,989.99. Following the completion of the transaction, the chief financial officer now owns 141,508 shares in the company, valued at $76,630,827.24. The disclosure for this sale can be found here. Insiders have sold a total of 130,144 shares of company stock valued at $69,269,555 over the last quarter. Company insiders own 0.40% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on UNH. Morgan Stanley increased their price target on UnitedHealth Group from $570.00 to $587.00 in a report on Monday, July 18th. Cowen raised their target price on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Truist Financial raised their target price on UnitedHealth Group from $575.00 to $610.00 in a report on Thursday, April 7th. Cowen raised their target price on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Finally, Loop Capital assumed coverage on UnitedHealth Group in a report on Thursday, June 16th. They set a “buy” rating and a $575.00 target price for the company. Three equities research analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $582.50.

About UnitedHealth Group

(Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Further Reading

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.